Genetic variants of the cytochrome P450 and glutathione S-transferase associated with risk of bladder cancer in a south-eastern Chinese population

International Journal of Urology

Volumn 15, Issue 3, 2008, Pages 216-221

  Shao, Jianfeng ^a   Gu, Min ^a   Zhang, Zhendong ^a   Xu, Zhuoqun ^a   Hu, Qiang ^a   Qian, Lixin ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Bladder cancer; Chinese population; Genetic variant; Molecular epidemiology; Susceptibility

Indexed keywords

CYTOCHROME P450 2E1; GLUTATHIONE TRANSFERASE M1;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER RISK; CHINESE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SMOKING; TRANSITIONAL CELL CARCINOMA;

CARCINOMA, TRANSITIONAL CELL; CASE-CONTROL STUDIES; CHINA; CYTOCHROME P-450 CYP2E1; FEMALE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; URINARY BLADDER NEOPLASMS;

EID: 39849084634     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2007.01915.x     Document Type: Article

References (33)

1. Parkin DM. International variation. Oncogene 2004 23 : 6329 40.
2. Yang L, Parkin DM, Li LD, Chen YD, Bray F. Estimation and projection of the national profile of cancer mortality in China: 1991-2005. Br. J. Cancer 2004 90 : 2157 66.
3. Cohen SM, Shirai T, Steineck G. Epidemiology and etiology of premalignant and malignant urothelial changes. Scand. J. Urol. Nephrol. Suppl. 2000 205 : 105 15.
4. Guengerich FP. Molecular advances for the cytochrome P-450 superfamily. Trends Pharmacol. Sci. 1991 12 : 281 3.
5. Yamazaki H, Inui Y, Yun CH, Guengerich FP, Shimada T. Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes. Carcinogenesis 1992 13 : 1789 94.
6. Lechevrel M, Casson AG, Wolf CR et al. Characterization of cytochrome P450 expression in human oesophageal mucosa. Carcinogenesis 1999 20 : 243 8.
7. Hu Y, Oscarson M, Johansson I et al. Genetic polymorphism of human CYP2E1: characterization of two variant alleles. Mol. Pharmacol. 1997 51 : 370 76.
8. Watanabe J, Hayashi S, Kawajiri K. Different regulation and expression of the human CYP2E1 gene due to the RsaI polymorphism in the 5′-flanking region. J. Biochem. (Tokyo) 1994 116 : 321 6.
9. Tan W, Song N, Wang GQ et al. Impact of genetic polymorphisms in cytochrome P450 2E1 and glutathione S-transferases M1, T1, and P1 on susceptibility to esophageal cancer among high-risk individuals in China. Cancer Epidemiol. Biomarkers Prev. 2000 9 : 551 6.
10. Singh SV, Xu BH, Tkalcevic GT, Gupta V, Roberts B, Ruiz P. Glutathione-linked detoxification pathway in normal and malignant human bladder tissue. Cancer Lett. 1994 77 : 15 24.
11. Parl FF. Glutathione S-transferase genotypes and cancer risk. Cancer Lett. 2005 221 : 123 9.
12. Liu S, Park JY, Schantz SP, Stern JC, Lazarus P. Elucidation of CYP2E1 5′ regulatory RsaI/Pstl allelic variants and their role in risk for oral cancer. Oral Oncol. 2001 37 : 437 45.
13. Brockmoller J, Cascorbi I, Kerb R, Roots I. Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk. Cancer Res. 1996 56 : 3915 25.
14. Farker K, Lehmann MH, Oelschlagel B et al. Impact of CYP2E1 genotype in renal cell and urothelial cancer patients. Exp. Toxicol. Pathol. 1998 50 : 425 31.
15. Anwar WA, Abdel-Rahman SZ, El-Zein RA, Mostafa HM, Au WW. Genetic polymorphism of GSTM1, CYP2E1 and CYP2D6 in Egyptian bladder cancer patients. Carcinogenesis 1996 17 : 1923 9.
16. Srivastava DS, Kumar A, Mittal B, Mittal RD. Polymorphism of GSTM1 and GSTT1 genes in bladder cancer: a study from North India. Arch. Toxicol. 2004 78 : 430 34.
17. Katoh T, Inatomi H, Kim H, Yang M, Matsumoto T, Kawamoto T. Effects of glutathione S-transferase (GST) M1 and GSTT1 genotypes on urothelial cancer risk. Cancer Lett. 1998 132 : 147 52.
18. Sobti RC, Al-Badran AI, Sharma S, Sharma SK, Krishan A, Mohan H. Genetic polymorphisms of CYP2D6, GSTM1, and GSTT1 genes and bladder cancer risk in North India. Cancer Genet. Cytogenet. 2005 156 : 68 73.
19. Ma QW, Lin GF, Chen JG, Shen JH. Polymorphism of glutathione S-transferase T1, M1 and P1 genes in a Shanghai population: patients with occupational or non-occupational bladder cancer. Biomed. Environ. Sci. 2002 15 : 253 60.
20. Lee SJ, Cho SH, Park SK et al. Combined effect of glutathione S-transferase M1 and T1 genotypes on bladder cancer risk. Cancer Lett. 2002 177 : 173 9.
21. Lin DX, Tang YM, Peng Q, Lu SX, Ambrosone CB, Kadlubar FF. Susceptibility to esophageal cancer and genetic polymorphisms in glutathione S-transferases T1, P1, and M1 and cytochrome P450 2E1. Cancer Epidemiol. Biomarkers Prev. 1998 7 : 1013 18.
22. Garcia-Closas M, Malats N, Silverman D et al. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet 2005 366 : 649 59.
23. Gao CM, Takezaki T, Wu JZ et al. Glutathione-S-transferases M1 (GSTM1) and GSTT1 genotype, smoking, consumption of alcohol and tea and risk of esophageal and stomach cancers: a case-control study of a high-incidence area in Jiangsu Province, China. Cancer Lett. 2002 188 : 95 102.
24. La Torre G, Boccia S, Ricciardi G. Glutathione S-transferase M1 status and gastric cancer risk: a meta-analysis. Cancer Lett. 2005 217 : 53 60.
25. Abdel-Rahman SZ, Anwar WA, Abdel-Aal WE, Mostafa HM, Au WW. GSTM1 and GSTT1 genes are potential risk modifiers for bladder cancer. Cancer Detect. Prev. 1998 22 : 129 38.
26. Brockmoller J, Cascorbi I, Kerb R, Sachse C, Roots I. Polymorphisms in xenobiotic conjugation and disease predisposition. Toxicol. Lett. 1998 102-103 : 173 83.
27. Rebbeck TR. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol. Biomarkers Prev. 1997 6 : 733 43.
28. Johns LE, Houlston RS. Glutathione S-transferase mu1 (GSTM1) status and bladder cancer risk: a meta-analysis. Mutagenesis 2000 15 : 399 404.
29. Karagas MR, Greenberg ER, Nierenberg D et al. Risk of squamous cell carcinoma of the skin in relation to plasma selenium, alpha-tocopherol, beta-carotene, and retinol: a nested case-control study. Cancer Epidemiol. Biomarkers Prev. 1997 6 : 25 9.
30. Karagas MR, Park S, Warren A et al. Gender, smoking, glutathione-S- transferase variants and bladder cancer incidence: a population-based study. Cancer Lett. 2005 219 : 63 9.
31. Srivastava DS, Mishra DK, Mandhani A et al. Association of genetic polymorphism of glutathione S-transferase M1, T1, P1 and susceptibility to bladder cancer. Eur. Urol. 2005 48 : 339 44.
32. Georgiou I, Filiadis IF, Alamanos Y et al. Glutathione S-transferase null genotypes in transitional cell bladder cancer: a case-control study. Eur. Urol. 2000 37 : 660 64.
33. Hirayama T. Cancer epidemiology in Japan. Environ. Health. Perspect. 1979 32 : 11 15.